Novogen Limited is a pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on the emerging field of isoflavonoid technology. The Company’s product development program embraces both the range of pharmaceuticals based on a range of phenolic compounds in humans and dietary supplements based on plant compounds known as isoflavones. In October 2006, the Company announced that it had licensed the United States rights to market Promensil and Trinovin brands to Natrol, Inc.
(Source: 20-F)
